Padcev 30 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQR6V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,212
Award facts
- Contract value 100% obligated
- $29,211.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,211.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 mg vials of Padcev, an oncology pharmaceutical. The award, issued on December 8, 2025, with completion targeted for December 30, 2025, represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned as a critical federal medical procurement vendor through its established relationship with DLA. The company's portfolio of federal contract awards demonstrates extensive experience fulfilling military and veteran healthcare pharmaceutical needs, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Padcev aligns with the company's core service offerings and its designated role as a prime vendor supporting the Defense Health Agency and other federal healthcare systems through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQR6V?
SPE2DR26FQR6V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FQR6V worth?
The government has obligated $29,212 on SPE2DR26FQR6V.
Is contract SPE2DR26FQR6V an order under another contract?
Yes. SPE2DR26FQR6V is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR6V competed?
The extent of competition for SPE2DR26FQR6V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award